Correlation Between Immunoprecise Antibodies and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Immunoprecise Antibodies and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunoprecise Antibodies and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunoprecise Antibodies and Allovir, you can compare the effects of market volatilities on Immunoprecise Antibodies and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunoprecise Antibodies with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunoprecise Antibodies and Allovir.

Diversification Opportunities for Immunoprecise Antibodies and Allovir

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Immunoprecise and Allovir is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Immunoprecise Antibodies and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Immunoprecise Antibodies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunoprecise Antibodies are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Immunoprecise Antibodies i.e., Immunoprecise Antibodies and Allovir go up and down completely randomly.

Pair Corralation between Immunoprecise Antibodies and Allovir

Considering the 90-day investment horizon Immunoprecise Antibodies is expected to generate 1.46 times more return on investment than Allovir. However, Immunoprecise Antibodies is 1.46 times more volatile than Allovir. It trades about 0.01 of its potential returns per unit of risk. Allovir is currently generating about -0.01 per unit of risk. If you would invest  1,035  in Immunoprecise Antibodies on July 3, 2022 and sell it today you would lose (636.00)  from holding Immunoprecise Antibodies or give up 61.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Immunoprecise Antibodies  vs.  Allovir

 Performance (%) 
       Timeline  
Immunoprecise Antibodies 
Immunoprecise Performance
2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Immunoprecise Antibodies are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Immunoprecise Antibodies may actually be approaching a critical reversion point that can send shares even higher in November 2022.

Immunoprecise Price Channel

Allovir 
Allovir Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allovir are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Allovir reported solid returns over the last few months and may actually be approaching a breakup point.

Allovir Price Channel

Immunoprecise Antibodies and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Immunoprecise Antibodies and Allovir

The main advantage of trading using opposite Immunoprecise Antibodies and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunoprecise Antibodies position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
Immunoprecise Antibodies vs. Brinker International
Immunoprecise Antibodies vs. Shake Shack
Immunoprecise Antibodies vs. Cheesecake Fact
Immunoprecise Antibodies vs. Mty Food Group
The idea behind Immunoprecise Antibodies and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Allovir vs. Scheid Vineyards
Allovir vs. Remy Cointreau Ff
Allovir vs. Endeavour Group
Allovir vs. Becle Sab DE
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go